Conference Menu
Current Event
2008 Overview
Day 1
Day 2
PDF Download
Press Pass
Request Brochure
Complimentary White Paper
21st Century Pharma: Managing Current Challenges to Ensure Future Growth
Arrive early and attend The Sixth Annual
Strategic Resource Management Executive Forum
November 17-18, 2008
Philadelphia, PA
Supporting Association
Corporate Sponsors
Corporate Support Sponsor:
Lead Sponsoring Publications:
Media Partners:
|
|
|
|
|
- Speaker Presentations
- Poster Abstracts
- and More!
|
Bring Your Entire Team!
Contact Call David Cunningham at 781.972.5472 for group discounts and company rates.
|
Utilizing Corporate Portfolio Management to Stop Investile Dysfunction
 Anand Sanwal, Managing Director, Brilliont; Former VP, Investment Optimization & Strategic Business Analysis, American Express
|
Portfolio Management in the Pharmaceutical Commercialization Space
 Poplin Kroese, Senior Analyst, Portfolio Management Strategy Deployment, Merck & Co.
|
Integrating Value into the Portfolio Decision-Making Framework
 Jean Lee, Director, WWD Portfolio Management, Pfizer; Co-developed with Lori S. Shafner, Vice President, Portfolio and Project Management, Pfizer |
Valuing a Diverse Portfolio: The Move from Selling Medicines to Promoting Health
 Marilyn Metcalf, Ph.D., Director, Quantitative and Decision Sciences, GlaxoSmithKline |
Evolution of Resource Management Capability at a Large Biotechnology Company
 Matthew Riddell, M.B.A., Associate Director, Research & Development Planning & Operations, Program & Alliance Management, Biogen Idec
|
Cost-Risk-Value Optimization – Enabling Drug Developers to “Do the right thing”
 Stephen A. Williams, Ph.D., Partner, Decisionability LLC; Former Vice President and Worldwide Head of Clinical Technology, Pfizer
|
Strategic Resource Management: Go Beyond Fancy Charts and Truly Impact Strategic Business Decisions
Christopher Beck, Vice President, Program Resources and Decision Support, Shire Pharmaceuticals
|
Successful Portfolio Management within Discovery at AstraZeneca
 Richard Lawson, Ph.D., Global Head of Discovery Decision Support, Discovery Strategy and Performance, AstraZeneca Pharmaceuticals, Inc.
|
Development Program Prioritization-Allocating Limited Resources in Any Business Environment
 Len Falsone, PE, Economics Manager, EP Americas, Shell Exlporation and Production Company |
Aligning Strategic Capacity Management with Business Development in Healthcare Product Safety
 Colin Cornhill, Senior Director, BRM Integration & Capacity Management, Johnson & Johnson Pharmaceutical R&D
|
Distinguished Faculty:
- Murray Aitken, Senior Vice President, Healthcare Insight, IMS Health Inc.
- Richard M. Bayney, Ph.D., President & Founder, Project & Portfolio Value Creation; Faculty, University of Pennsylvania
- Sabine Bernotat-Danielowski, Ph.D., MBA, Executive Director, Decision Analysis, Daiichi Sankyo
- Robin G. Foldesy, Ph.D., Vice President, Portfolio Management, Wyeth Research
- Richard J. Heaslip, Ph.D., Vice President, Project & Portfolio Management, Wyeth Research
- Peter Heinrich, Ph.D., CEO, Portfolio DecisionWare, Inc.
- Jeff Hewitt, Senior Principal, SDG life sciences, a unit of IMS
- Jennifer Hirsch, Associate Director, R&D Operations, Johnson & Johnson Pharmaceutical R&D
- J. Mark Horn, Director, Finance and R&D Portfolio Management, Wyeth Consumer Healthcare
- John I. Howell III, President, Portfolio Decisions, Inc.
- Matthew Kiernan, Partner, Pharmica Consulting
- Poplin Kroese, Senior Analyst, Portfolio Management Strategy Deployment, Merck & Co.
- Maureen Martini, Senior Project Manager, Global Strategic Planning and Program Management, Shire Pharmaceuticals
- Grant Morgan, Ph.D., PMP, Leader of R&D Metrics and Capacity Management, Allergan, Inc.
- Chad Nikel, Director of Business Development, Integrated Project Management
- Paul Ranky, Ph.D., Professor, Department of Industrial and Management Systems Engineering and IT, NJIT
- James F. Resch, Ph.D., Director, Strategic Intelligence, Discovery Strategy and Performance, AstraZeneca
- Otto Ritter, Ph.D., Associate Director, Global Discovery Information, AstraZeneca
- Vladimir Shnaydman, Ph.D, President, ORBee Consulting
- Michael Shulman, Editor/Analyst, ChangeWave
- Daniel Smith, Vice President, Enrich Consulting
- Lillian Warren, Chief Operating Officer, Portfolio Decisions, Inc.
Overview | Day 1 | Day 2 | Go to Strategic Resource Management Conference
|
|
|